Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Environmental Exposure | 23 | 2024 | 4543 | 2.780 |
Why?
|
Nutrition Surveys | 28 | 2024 | 1741 | 2.660 |
Why?
|
Drug Repositioning | 6 | 2018 | 246 | 2.490 |
Why?
|
Metagenomics | 5 | 2023 | 473 | 1.750 |
Why?
|
Computational Biology | 13 | 2024 | 3559 | 1.650 |
Why?
|
Disease | 6 | 2019 | 676 | 1.330 |
Why?
|
Environmental Pollutants | 8 | 2024 | 1291 | 1.320 |
Why?
|
Metagenome | 4 | 2023 | 464 | 1.310 |
Why?
|
Diabetes Mellitus, Type 2 | 15 | 2024 | 12240 | 1.140 |
Why?
|
Endocrine Disruptors | 2 | 2021 | 249 | 1.080 |
Why?
|
Environmental Health | 6 | 2021 | 297 | 1.060 |
Why?
|
Toxicogenetics | 3 | 2016 | 19 | 0.970 |
Why?
|
Prediabetic State | 2 | 2021 | 548 | 0.960 |
Why?
|
Databases, Factual | 11 | 2019 | 8067 | 0.900 |
Why?
|
Epidemiologic Research Design | 3 | 2020 | 368 | 0.890 |
Why?
|
Biological Specimen Banks | 3 | 2024 | 786 | 0.880 |
Why?
|
Software | 10 | 2024 | 4462 | 0.870 |
Why?
|
Government | 1 | 2024 | 161 | 0.850 |
Why?
|
Extreme Heat | 1 | 2023 | 60 | 0.810 |
Why?
|
Genetic Predisposition to Disease | 13 | 2024 | 18071 | 0.700 |
Why?
|
Models, Statistical | 6 | 2021 | 5089 | 0.700 |
Why?
|
Genome, Human | 5 | 2018 | 4448 | 0.690 |
Why?
|
Blood Glucose | 6 | 2024 | 6425 | 0.670 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 12807 | 0.650 |
Why?
|
Semen Analysis | 2 | 2018 | 237 | 0.650 |
Why?
|
Genetic Association Studies | 7 | 2024 | 2741 | 0.640 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2024 | 3247 | 0.610 |
Why?
|
Disease Transmission, Infectious | 1 | 2024 | 560 | 0.600 |
Why?
|
Genetic Variation | 10 | 2019 | 6610 | 0.580 |
Why?
|
Phenotype | 16 | 2024 | 16721 | 0.570 |
Why?
|
Medical Subject Headings | 1 | 2017 | 16 | 0.560 |
Why?
|
Biostatistics | 1 | 2019 | 162 | 0.560 |
Why?
|
Humans | 131 | 2024 | 765956 | 0.550 |
Why?
|
Lyme Disease | 1 | 2023 | 631 | 0.540 |
Why?
|
Twins, Monozygotic | 1 | 2018 | 469 | 0.510 |
Why?
|
Semen | 1 | 2018 | 354 | 0.510 |
Why?
|
Phthalic Acids | 1 | 2021 | 485 | 0.510 |
Why?
|
Bupropion | 1 | 2018 | 303 | 0.510 |
Why?
|
Fatty Liver | 1 | 2022 | 807 | 0.500 |
Why?
|
Fertilization | 1 | 2016 | 197 | 0.500 |
Why?
|
Fertility | 2 | 2018 | 768 | 0.490 |
Why?
|
Risk Factors | 31 | 2024 | 74836 | 0.490 |
Why?
|
Sperm Motility | 1 | 2016 | 265 | 0.490 |
Why?
|
Environment | 5 | 2020 | 1114 | 0.480 |
Why?
|
Body Height | 1 | 2021 | 1562 | 0.480 |
Why?
|
Epidemiologic Methods | 2 | 2021 | 1326 | 0.480 |
Why?
|
Epidemiologic Studies | 3 | 2015 | 677 | 0.470 |
Why?
|
Bacteria | 3 | 2022 | 2209 | 0.460 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9524 | 0.460 |
Why?
|
Biomedical Research | 2 | 2022 | 3458 | 0.440 |
Why?
|
Mortality | 3 | 2024 | 2904 | 0.440 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2013 | 49 | 0.440 |
Why?
|
Mendelian Randomization Analysis | 2 | 2019 | 1044 | 0.440 |
Why?
|
Cholesterol | 2 | 2020 | 2898 | 0.420 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5891 | 0.420 |
Why?
|
Models, Theoretical | 6 | 2024 | 3564 | 0.410 |
Why?
|
Hyperglycemia | 2 | 2021 | 1393 | 0.410 |
Why?
|
Data Interpretation, Statistical | 3 | 2024 | 2686 | 0.400 |
Why?
|
Reproduction | 1 | 2017 | 641 | 0.400 |
Why?
|
Spermatozoa | 1 | 2016 | 629 | 0.400 |
Why?
|
Phenols | 2 | 2013 | 522 | 0.400 |
Why?
|
Blood | 1 | 2015 | 597 | 0.390 |
Why?
|
Breast Feeding | 1 | 2020 | 1363 | 0.380 |
Why?
|
Cause of Death | 2 | 2024 | 3708 | 0.370 |
Why?
|
Genetics, Population | 3 | 2013 | 943 | 0.370 |
Why?
|
Fasting | 3 | 2024 | 1606 | 0.370 |
Why?
|
Aging | 3 | 2020 | 8731 | 0.360 |
Why?
|
Insulin Resistance | 4 | 2022 | 3985 | 0.360 |
Why?
|
Telomere | 1 | 2017 | 943 | 0.350 |
Why?
|
Computer Simulation | 6 | 2024 | 6255 | 0.350 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15398 | 0.350 |
Why?
|
Exercise | 2 | 2024 | 5937 | 0.340 |
Why?
|
Communicable Diseases | 1 | 2018 | 874 | 0.330 |
Why?
|
Environmental Monitoring | 4 | 2017 | 1470 | 0.330 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1461 | 0.330 |
Why?
|
Benzhydryl Compounds | 2 | 2013 | 939 | 0.320 |
Why?
|
Dementia | 1 | 2024 | 2744 | 0.320 |
Why?
|
Male | 53 | 2024 | 363691 | 0.320 |
Why?
|
Risk Assessment | 9 | 2024 | 24283 | 0.320 |
Why?
|
Prescription Drugs | 1 | 2016 | 634 | 0.320 |
Why?
|
Socioeconomic Factors | 4 | 2023 | 7836 | 0.300 |
Why?
|
Adult | 39 | 2024 | 223038 | 0.300 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4247 | 0.300 |
Why?
|
Sexual Behavior | 1 | 2018 | 2193 | 0.300 |
Why?
|
Female | 50 | 2024 | 396101 | 0.290 |
Why?
|
United States | 20 | 2024 | 72898 | 0.290 |
Why?
|
Pharmaceutical Preparations | 1 | 2016 | 1084 | 0.290 |
Why?
|
Body Mass Index | 7 | 2022 | 13039 | 0.280 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2659 | 0.270 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3796 | 0.270 |
Why?
|
Occupational Exposure | 1 | 2017 | 1805 | 0.270 |
Why?
|
Middle Aged | 32 | 2024 | 223004 | 0.270 |
Why?
|
Maternal Exposure | 1 | 2013 | 1096 | 0.260 |
Why?
|
Cohort Studies | 13 | 2023 | 41647 | 0.260 |
Why?
|
Income | 1 | 2015 | 1874 | 0.260 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7478 | 0.240 |
Why?
|
Public Health | 3 | 2017 | 2680 | 0.240 |
Why?
|
Carotenoids | 3 | 2013 | 619 | 0.240 |
Why?
|
Cross-Sectional Studies | 13 | 2024 | 26313 | 0.240 |
Why?
|
Coronary Disease | 1 | 2019 | 5912 | 0.240 |
Why?
|
Nutrition Policy | 2 | 2019 | 467 | 0.230 |
Why?
|
Kidney Neoplasms | 2 | 2021 | 4274 | 0.220 |
Why?
|
Prevalence | 7 | 2024 | 15839 | 0.220 |
Why?
|
Multivariate Analysis | 5 | 2018 | 12057 | 0.220 |
Why?
|
Obesity | 4 | 2023 | 13075 | 0.220 |
Why?
|
Reference Values | 3 | 2021 | 4908 | 0.220 |
Why?
|
Young Adult | 17 | 2024 | 59886 | 0.220 |
Why?
|
Motor Activity | 1 | 2013 | 2704 | 0.220 |
Why?
|
Smoking | 3 | 2023 | 9081 | 0.220 |
Why?
|
Blood Pressure | 2 | 2016 | 8532 | 0.210 |
Why?
|
Cluster Analysis | 4 | 2021 | 2720 | 0.210 |
Why?
|
Diabetic Nephropathies | 2 | 2024 | 969 | 0.210 |
Why?
|
Delphi Technique | 2 | 2024 | 893 | 0.200 |
Why?
|
Climate | 1 | 2023 | 147 | 0.200 |
Why?
|
Linear Models | 3 | 2018 | 5876 | 0.200 |
Why?
|
Prostatic Neoplasms | 5 | 2020 | 11083 | 0.200 |
Why?
|
Chronic Disease | 3 | 2023 | 9347 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2021 | 16047 | 0.200 |
Why?
|
Weather | 1 | 2023 | 234 | 0.200 |
Why?
|
Health Surveys | 3 | 2020 | 4056 | 0.190 |
Why?
|
Health Status | 1 | 2015 | 4080 | 0.190 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15651 | 0.190 |
Why?
|
Cardiac Imaging Techniques | 1 | 2024 | 280 | 0.190 |
Why?
|
Premature Birth | 1 | 2013 | 1829 | 0.190 |
Why?
|
Sample Size | 3 | 2021 | 845 | 0.190 |
Why?
|
Algorithms | 8 | 2024 | 14071 | 0.180 |
Why?
|
Neoplasms | 6 | 2022 | 22340 | 0.180 |
Why?
|
Netherlands | 3 | 2021 | 2277 | 0.180 |
Why?
|
Lipids | 1 | 2012 | 3316 | 0.180 |
Why?
|
Eligibility Determination | 1 | 2024 | 423 | 0.180 |
Why?
|
Waist Circumference | 2 | 2022 | 933 | 0.180 |
Why?
|
HIV-1 | 1 | 2018 | 6944 | 0.180 |
Why?
|
Asthma | 1 | 2019 | 6270 | 0.170 |
Why?
|
Parabens | 1 | 2021 | 117 | 0.170 |
Why?
|
Databases, Genetic | 3 | 2018 | 1751 | 0.170 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 145 | 0.170 |
Why?
|
Receptors, GABA-A | 1 | 2024 | 624 | 0.170 |
Why?
|
Aged | 18 | 2024 | 171114 | 0.170 |
Why?
|
Drinking Behavior | 1 | 2020 | 101 | 0.170 |
Why?
|
Infant | 9 | 2024 | 36385 | 0.160 |
Why?
|
Pharmacoepidemiology | 1 | 2023 | 351 | 0.160 |
Why?
|
TRPP Cation Channels | 1 | 2020 | 177 | 0.160 |
Why?
|
Micrognathism | 1 | 2019 | 63 | 0.160 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1693 | 0.160 |
Why?
|
Psychopathology | 1 | 2022 | 435 | 0.160 |
Why?
|
California | 1 | 2023 | 1436 | 0.160 |
Why?
|
Meat Products | 1 | 2019 | 97 | 0.160 |
Why?
|
Micronutrients | 2 | 2012 | 390 | 0.160 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2495 | 0.160 |
Why?
|
Coloboma | 1 | 2019 | 60 | 0.160 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2020 | 166 | 0.160 |
Why?
|
Vibration | 1 | 2021 | 334 | 0.160 |
Why?
|
Trypsinogen | 1 | 2018 | 84 | 0.160 |
Why?
|
Sex Factors | 3 | 2020 | 10602 | 0.160 |
Why?
|
Family Characteristics | 1 | 2024 | 1001 | 0.150 |
Why?
|
Genetic Testing | 2 | 2023 | 3595 | 0.150 |
Why?
|
Programming, Linear | 1 | 2018 | 8 | 0.150 |
Why?
|
Age Factors | 3 | 2024 | 18380 | 0.150 |
Why?
|
Air Pollution | 2 | 2023 | 2380 | 0.150 |
Why?
|
Life Style | 3 | 2020 | 3926 | 0.150 |
Why?
|
Hand Deformities, Congenital | 1 | 2019 | 175 | 0.150 |
Why?
|
Delayed Graft Function | 1 | 2018 | 50 | 0.150 |
Why?
|
Air Pollutants | 2 | 2023 | 2923 | 0.150 |
Why?
|
Research Design | 4 | 2023 | 6208 | 0.150 |
Why?
|
Trypsin | 1 | 2018 | 487 | 0.150 |
Why?
|
Geography | 1 | 2020 | 652 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2022 | 2429 | 0.150 |
Why?
|
Adolescent | 13 | 2024 | 88832 | 0.150 |
Why?
|
Prospective Studies | 8 | 2021 | 54806 | 0.140 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 735 | 0.140 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 1043 | 0.140 |
Why?
|
Heart Failure | 1 | 2022 | 11840 | 0.140 |
Why?
|
Validation Studies as Topic | 1 | 2018 | 162 | 0.140 |
Why?
|
Nervous System Malformations | 1 | 2019 | 243 | 0.140 |
Why?
|
Twins | 1 | 2019 | 341 | 0.140 |
Why?
|
Cadmium | 2 | 2020 | 218 | 0.140 |
Why?
|
Asparaginase | 1 | 2018 | 240 | 0.140 |
Why?
|
Mifepristone | 1 | 2018 | 150 | 0.140 |
Why?
|
MEDLINE | 1 | 2017 | 120 | 0.140 |
Why?
|
RNA Splicing | 1 | 2021 | 903 | 0.140 |
Why?
|
Embolism, Fat | 1 | 2017 | 46 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1187 | 0.140 |
Why?
|
Climate Change | 1 | 2023 | 509 | 0.130 |
Why?
|
Self Report | 2 | 2020 | 3771 | 0.130 |
Why?
|
Species Specificity | 1 | 2021 | 2406 | 0.130 |
Why?
|
T-Box Domain Proteins | 1 | 2019 | 469 | 0.130 |
Why?
|
Temperature | 1 | 2023 | 2226 | 0.130 |
Why?
|
Alleles | 4 | 2024 | 6897 | 0.130 |
Why?
|
Specialization | 1 | 2021 | 777 | 0.130 |
Why?
|
Epilepsy | 2 | 2024 | 3320 | 0.130 |
Why?
|
Donor Selection | 1 | 2018 | 242 | 0.130 |
Why?
|
Hypertension | 1 | 2016 | 8626 | 0.130 |
Why?
|
Fumarates | 1 | 2017 | 132 | 0.130 |
Why?
|
Child, Preschool | 9 | 2024 | 42500 | 0.130 |
Why?
|
Diet | 4 | 2019 | 8086 | 0.130 |
Why?
|
Sperm Count | 1 | 2016 | 227 | 0.130 |
Why?
|
Pandemics | 3 | 2024 | 8701 | 0.120 |
Why?
|
Coffee | 1 | 2020 | 593 | 0.120 |
Why?
|
Insurance, Health | 2 | 2019 | 2520 | 0.120 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 605 | 0.120 |
Why?
|
Thyroid Nodule | 1 | 2023 | 779 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1240 | 0.120 |
Why?
|
Body Dysmorphic Disorders | 1 | 2019 | 242 | 0.120 |
Why?
|
Pregnancy, Ectopic | 1 | 2017 | 146 | 0.120 |
Why?
|
Population Groups | 1 | 2016 | 209 | 0.120 |
Why?
|
Feces | 1 | 2022 | 1504 | 0.120 |
Why?
|
Pancreas | 1 | 2022 | 1700 | 0.120 |
Why?
|
Oligonucleotide Probes | 1 | 2015 | 417 | 0.120 |
Why?
|
Waist-Hip Ratio | 1 | 2016 | 520 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2024 | 1299 | 0.120 |
Why?
|
Fibrosis | 1 | 2022 | 2070 | 0.120 |
Why?
|
Australia | 3 | 2024 | 1258 | 0.120 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2015 | 25 | 0.120 |
Why?
|
Renal Dialysis | 1 | 2024 | 1799 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 790 | 0.120 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2033 | 0.120 |
Why?
|
Neck | 1 | 2019 | 733 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3202 | 0.110 |
Why?
|
Amides | 1 | 2017 | 455 | 0.110 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 456 | 0.110 |
Why?
|
beta Catenin | 1 | 2019 | 1043 | 0.110 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2194 | 0.110 |
Why?
|
Selection, Genetic | 1 | 2018 | 878 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2832 | 0.110 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12509 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 370 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1369 | 0.110 |
Why?
|
Face | 1 | 2019 | 1028 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2016 | 738 | 0.110 |
Why?
|
Triclosan | 1 | 2013 | 59 | 0.110 |
Why?
|
Homosexuality, Female | 1 | 2015 | 171 | 0.110 |
Why?
|
India | 1 | 2020 | 2334 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2018 | 747 | 0.100 |
Why?
|
Models, Genetic | 3 | 2017 | 3448 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 1188 | 0.100 |
Why?
|
Bisexuality | 1 | 2015 | 295 | 0.100 |
Why?
|
Colorectal Neoplasms | 3 | 2022 | 6942 | 0.100 |
Why?
|
Child | 11 | 2024 | 80563 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1333 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2233 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2024 | 26349 | 0.100 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2021 | 2203 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2794 | 0.100 |
Why?
|
Pesticides | 2 | 2018 | 296 | 0.100 |
Why?
|
Ecosystem | 1 | 2016 | 488 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14749 | 0.100 |
Why?
|
Abnormalities, Multiple | 1 | 2019 | 1424 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2018 | 2352 | 0.100 |
Why?
|
Virulence | 1 | 2016 | 1289 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2122 | 0.100 |
Why?
|
Cerebellum | 1 | 2019 | 1518 | 0.100 |
Why?
|
Haplotypes | 1 | 2018 | 2728 | 0.100 |
Why?
|
RNA | 1 | 2021 | 2717 | 0.100 |
Why?
|
Pancreatitis | 1 | 2018 | 1087 | 0.090 |
Why?
|
HIV Infections | 1 | 2018 | 17533 | 0.090 |
Why?
|
Retrospective Studies | 9 | 2024 | 81515 | 0.090 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1959 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 488 | 0.090 |
Why?
|
Pregnancy | 4 | 2018 | 30258 | 0.090 |
Why?
|
Reproducibility of Results | 7 | 2024 | 20125 | 0.090 |
Why?
|
Nutritional Status | 3 | 2017 | 1620 | 0.090 |
Why?
|
Vitamin E | 1 | 2015 | 869 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2226 | 0.090 |
Why?
|
Electronic Health Records | 3 | 2023 | 4873 | 0.090 |
Why?
|
gamma-Tocopherol | 1 | 2010 | 29 | 0.090 |
Why?
|
Incidence | 2 | 2021 | 21480 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1519 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11888 | 0.090 |
Why?
|
Emigration and Immigration | 1 | 2013 | 405 | 0.080 |
Why?
|
Genotype | 4 | 2024 | 13024 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 437 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2108 | 0.080 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 989 | 0.080 |
Why?
|
Prognosis | 4 | 2024 | 29921 | 0.080 |
Why?
|
Medication Adherence | 1 | 2021 | 2190 | 0.080 |
Why?
|
Gene Frequency | 2 | 2016 | 3624 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3251 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1560 | 0.080 |
Why?
|
Proteins | 1 | 2024 | 5995 | 0.080 |
Why?
|
Hazardous Substances | 1 | 2010 | 153 | 0.080 |
Why?
|
Genomics | 3 | 2022 | 5929 | 0.080 |
Why?
|
Glucose | 1 | 2021 | 4335 | 0.080 |
Why?
|
Glioma | 1 | 2024 | 3493 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9591 | 0.080 |
Why?
|
Leukocytes | 1 | 2017 | 2027 | 0.080 |
Why?
|
Kidney Calculi | 1 | 2013 | 457 | 0.080 |
Why?
|
Tissue Donors | 1 | 2018 | 2395 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4622 | 0.070 |
Why?
|
Polychlorinated Biphenyls | 1 | 2010 | 234 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2024 | 59488 | 0.070 |
Why?
|
Mental Health | 1 | 2022 | 3272 | 0.070 |
Why?
|
Pain | 1 | 2023 | 5077 | 0.070 |
Why?
|
Dietary Fats | 1 | 2015 | 2002 | 0.070 |
Why?
|
Fatty Acids | 1 | 2015 | 1806 | 0.070 |
Why?
|
Bayes Theorem | 3 | 2023 | 2354 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2744 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13648 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3446 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3213 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1534 | 0.070 |
Why?
|
Potassium, Dietary | 2 | 2020 | 103 | 0.070 |
Why?
|
Feeding Behavior | 2 | 2015 | 3211 | 0.070 |
Why?
|
Adiposity | 1 | 2016 | 1890 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3181 | 0.070 |
Why?
|
Liver | 1 | 2022 | 7562 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 1378 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2012 | 1811 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2022 | 8927 | 0.060 |
Why?
|
Health Promotion | 1 | 2017 | 2208 | 0.060 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2005 | 53 | 0.060 |
Why?
|
Graft Rejection | 1 | 2018 | 4499 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3110 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2822 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3318 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2017 | 3850 | 0.060 |
Why?
|
Chorioallantoic Membrane | 1 | 2005 | 50 | 0.060 |
Why?
|
Medical History Taking | 1 | 2008 | 777 | 0.060 |
Why?
|
Veterans Disability Claims | 1 | 2024 | 24 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10383 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2441 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 7584 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11501 | 0.050 |
Why?
|
Medicaid | 1 | 2017 | 2831 | 0.050 |
Why?
|
Mutation | 4 | 2021 | 30196 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4270 | 0.050 |
Why?
|
Estradiol | 1 | 2010 | 1947 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9071 | 0.050 |
Why?
|
Spin Labels | 1 | 2024 | 334 | 0.050 |
Why?
|
Odds Ratio | 3 | 2024 | 9649 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 2393 | 0.050 |
Why?
|
Family | 2 | 2015 | 3209 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9747 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1405 | 0.050 |
Why?
|
Ovarian Neoplasms | 2 | 2016 | 4900 | 0.050 |
Why?
|
Databases, Protein | 1 | 2024 | 391 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8728 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1509 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3229 | 0.050 |
Why?
|
Spirometry | 1 | 2024 | 929 | 0.040 |
Why?
|
Chemokine CCL22 | 1 | 2020 | 27 | 0.040 |
Why?
|
Clinical Chemistry Tests | 1 | 2020 | 59 | 0.040 |
Why?
|
Financing, Government | 1 | 2024 | 473 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.040 |
Why?
|
Blindness | 1 | 2024 | 586 | 0.040 |
Why?
|
gamma-Glutamyltransferase | 1 | 2020 | 140 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2015 | 4300 | 0.040 |
Why?
|
Ethics, Research | 1 | 2021 | 178 | 0.040 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2020 | 86 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2020 | 233 | 0.040 |
Why?
|
American Heart Association | 1 | 2024 | 1047 | 0.040 |
Why?
|
DNA Fingerprinting | 1 | 2019 | 114 | 0.040 |
Why?
|
Conflict of Interest | 1 | 2024 | 556 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 197 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8611 | 0.040 |
Why?
|
Perfusion | 1 | 2024 | 1407 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5526 | 0.040 |
Why?
|
England | 1 | 2020 | 533 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15880 | 0.040 |
Why?
|
Computer Communication Networks | 1 | 2020 | 292 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 751 | 0.040 |
Why?
|
Muscle Spasticity | 1 | 2019 | 160 | 0.040 |
Why?
|
Bilirubin | 1 | 2020 | 439 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36532 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 714 | 0.040 |
Why?
|
Genome, Bacterial | 1 | 2023 | 797 | 0.040 |
Why?
|
Probability | 1 | 2023 | 2475 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2005 | 1375 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 854 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1073 | 0.040 |
Why?
|
Triolein | 1 | 2017 | 9 | 0.040 |
Why?
|
Serum Albumin | 1 | 2020 | 675 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2024 | 1820 | 0.030 |
Why?
|
National Health Programs | 1 | 2020 | 443 | 0.030 |
Why?
|
Vehicle Emissions | 1 | 2021 | 651 | 0.030 |
Why?
|
Mouth | 1 | 2019 | 381 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1602 | 0.030 |
Why?
|
Logistic Models | 2 | 2024 | 13266 | 0.030 |
Why?
|
Magnesium | 1 | 2020 | 813 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2017 | 221 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2023 | 1737 | 0.030 |
Why?
|
Biodiversity | 1 | 2019 | 346 | 0.030 |
Why?
|
Multigene Family | 1 | 2019 | 1080 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2024 | 1456 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 761 | 0.030 |
Why?
|
Caffeine | 1 | 2020 | 702 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5444 | 0.030 |
Why?
|
Microcephaly | 1 | 2019 | 426 | 0.030 |
Why?
|
Brain Death | 1 | 2018 | 360 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1915 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2024 | 1311 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2016 | 21056 | 0.030 |
Why?
|
Lead | 1 | 2020 | 879 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2019 | 1130 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2673 | 0.030 |
Why?
|
Lung Diseases | 1 | 2024 | 1940 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2035 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4015 | 0.030 |
Why?
|
Schools | 1 | 2022 | 1492 | 0.030 |
Why?
|
Diet Records | 1 | 2015 | 425 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 834 | 0.030 |
Why?
|
Social Class | 1 | 2022 | 2007 | 0.030 |
Why?
|
Folic Acid | 1 | 2020 | 1339 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 1005 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3423 | 0.030 |
Why?
|
Human Genome Project | 1 | 2013 | 202 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4520 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2022 | 2115 | 0.020 |
Why?
|
Peptides | 1 | 2024 | 4331 | 0.020 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2013 | 84 | 0.020 |
Why?
|
Vitiligo | 1 | 2013 | 96 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1736 | 0.020 |
Why?
|
Vitamins | 1 | 2020 | 1630 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2020 | 2464 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4108 | 0.020 |
Why?
|
Contrast Media | 1 | 2024 | 5329 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2858 | 0.020 |
Why?
|
Alopecia Areata | 1 | 2013 | 129 | 0.020 |
Why?
|
Vitamin B Complex | 1 | 2012 | 299 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9443 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2016 | 13451 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1721 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1831 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2015 | 721 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10563 | 0.020 |
Why?
|
Particulate Matter | 1 | 2021 | 2624 | 0.020 |
Why?
|
Ultrasonography | 1 | 2023 | 5993 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1892 | 0.020 |
Why?
|
Scleroderma, Systemic | 1 | 2013 | 346 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5302 | 0.020 |
Why?
|
Sodium, Dietary | 1 | 2012 | 426 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3134 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1604 | 0.020 |
Why?
|
Minority Groups | 1 | 2015 | 1207 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13400 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3890 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12795 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7425 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4526 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8297 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6321 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4772 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8102 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11022 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3655 | 0.010 |
Why?
|
Energy Intake | 1 | 2012 | 2140 | 0.010 |
Why?
|
Forecasting | 1 | 2014 | 2936 | 0.010 |
Why?
|
Chick Embryo | 1 | 2005 | 964 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4058 | 0.010 |
Why?
|
Signal Transduction | 1 | 2005 | 23600 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 17075 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2013 | 1915 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2176 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23707 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2013 | 2159 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2825 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4040 | 0.010 |
Why?
|
Animals | 3 | 2019 | 168759 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6599 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40065 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18294 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5743 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39194 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2005 | 2453 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15747 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12403 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12769 | 0.010 |
Why?
|